Content Type (RSS): In the News

  • Top State and Local Tax Policies of 2024: Midyear Report

    Top State and Local Tax Policies of 2024: Midyear Report

    COVERAGE

    Top State and Local Tax Policies of 2024: Midyear Report

    July 5, 2024

    Read time: 2 min

    About Us

    Stephen P. Kranz

    Partner

    Washington, DC

    You may also like

  • Chevron’s Fall Places State Tax Rules Under Microscope

    Chevron’s Fall Places State Tax Rules Under Microscope

    COVERAGE

    Chevron’s Fall Places State Tax Rules Under Microscope

    July 2, 2024

    Read time: 2 min

    About Us

    Michael J. Hilkin

    Partner

    New York – One Vanderbilt Avenue

    You may also like

  • Supreme Court’s Overturning of Chevron Could Cause Tax Shake-up

    Supreme Court’s Overturning of Chevron Could Cause Tax Shake-up

    COVERAGE

    Supreme Court’s Overturning of Chevron Could Cause Tax Shake-up

    July 1, 2024

    Read time: 2 min

    About Us

    David G. Noren

    Partner

    Washington, DC

    You may also like

  • McDermott Advises Ligand on Acquisition of APEIRON Biologics

    McDermott Advises Ligand on Acquisition of APEIRON Biologics

    DEAL ANNOUNCEMENT / PRESS RELEASE

    McDermott Advises Ligand on Acquisition of APEIRON Biologics

    July 12, 2024

    Read time: 3 min

    Duesseldorf, July 12, 2024 – International law firm McDermott Will & Emery advises Ligand Pharmaceuticals Incorporated on the planned acquisition of all shares in the Austrian stock corporation APEIRON Biologics AG.

    Upon closing of the transaction, Ligand shall acquire all the outstanding shares of APEIRON for $100 million in cash. Ligand will also pay APEIRON shareholders additional consideration based on future commercial and regulatory events, including up to $28 million if royalties from APEIRON’s co-developed drug QARZIBA exceed certain pre-determined thresholds by 2030 or 2034, respectively.

    The transaction is expected to close in July 2024.

    APEIRON is a biopharmaceutical company based in Vienna, Austria. The company holds the royalty rights to the cancer drug QARZIBA®, which it co-developed. QARZIBA was approved by the European Medicines Agency in 2017 and is now available in more than 35 countries.

    Ligand Pharmaceuticals is a biopharmaceutical company that invests in the clinical development and commercialization of high value drugs. Ligand manages one of the largest biopharmaceutical royalty portfolios with more than 100 partnered programs in commercial and development stages.

    The McDermott team is led by partners Uwe Goetker and Sebastian Bonk (Corporate/M&A) and comprised senior counsel Gary Howes (Corporate/M&A), counsel  Marcus Fischer (U.S. & International Tax) as well as associates Sebastian Klein, Jan Lorenzen, Hubertus von Bornstaedt, and Nils Ladewig (all Corporate/M&A).

    About Us

    Dr. Uwe Goetker

    Partner

    Düsseldorf

    Sebastian Bonk

    Partner

    Düsseldorf

    Marcus Fischer

    Counsel

    Frankfurt

    Nils Ladewig

    Associate

    Düsseldorf

    You may also like

  • Reading Between the Lines of Justices’ Moore Ruling

    Reading Between the Lines of Justices’ Moore Ruling

    COVERAGE

    Reading Between the Lines of Justices’ Moore Ruling

    July 15, 2024

    Read time: 2 min

    About Us

    Caroline H. Ngo

    Partner

    Washington, DC

    You may also like

  • McDermott Advises Apex Clean Energy in Two IRA-Supported Texas Storage Facility Financings Totaling 200 MW

    McDermott Advises Apex Clean Energy in Two IRA-Supported Texas Storage Facility Financings Totaling 200 MW

    DEAL ANNOUNCEMENT / PRESS RELEASE

    McDermott Advises Apex Clean Energy in Two IRA-Supported Texas Storage Facility Financings Totaling 200 MW

    July 15, 2024

    Read time: 4 min

    International law firm McDermott Will & Emery represented Apex Clean Energy (Apex), a leader in renewable energy, in partnership with First Citizens Bank Energy Finance, on two financings totaling more than $150 million for battery energy storage projects in Texas. These are two of the largest energy storage financings under the Inflation Reduction Act (IRA) and leverage the IRA’s tax credit transferability. The facilities are:

    • Great Kiskadee Storage: 100 MW/200 MWh battery energy storage system under construction in Hidalgo County, Texas.
    • Angelo Storage: 100 MW/200 MWh battery energy storage system under construction in Green County, Texas.

    “We are pleased to have advised on this sophisticated financing for Apex, which will optimize its capital structure and further position Apex for continued growth,” said Energy and Project Finance partner Carl Fleming. “This innovative financing leverages the tax credit transferability mechanism under the IRA and optimizes the value of the projects for Apex, one of our most valued and longstanding clients.”

    “Great Kiskadee and Angelo showcase the transformative impact of the IRA on accelerating energy storage deployment,” said Kurt Friesen, Apex General Counsel. “McDermott’s expertise and approach in navigating these complex transactions has been crucial in optimizing and advancing our projects under this new regulatory landscape.”

    The McDermott energy and project finance team was led by partners Carl Fleming, Philip Tingle, Heather Cooper, Jim Salerno and Seth Doughty with support from associates Andrew Kim, Garrett Brann and Olivia Johnson.

    Working closely with Apex’s leading finance team, McDermott’s Energy and Project Finance team brought extensive IRA, tax credit and tax equity finance experience to the transaction. McDermott was the first law firm to close a post-IRA tax credit transfer in January 2023 and has since closed over 55 post-IRA tax credit transfer driven transactions.

    Read Apex’s announcement.

    About Us

    McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

    Carl J. Fleming

    Partner

    Washington, DC

    Philip Tingle

    Partner

    Miami

    Heather Cooper

    Partner

    Miami

    Seth B. Doughty

    Partner

    Los Angeles

    Andrew Kim

    Partner

    New York – One Vanderbilt Avenue

    Olivia D. Johnson

    Associate

    Miami

    You may also like

  • FTC Fails to Obtain Preliminary Injunction to Block Novant’s Acquisition of Two CHS Hospitals

    FTC Fails to Obtain Preliminary Injunction to Block Novant’s Acquisition of Two CHS Hospitals

    COVERAGE

    FTC Fails to Obtain Preliminary Injunction to Block Novant’s Acquisition of Two CHS Hospitals

    June 14, 2024

    Read time: 2 min

    About Us

    Noah Feldman Greene

    Partner

    Washington, DC

    You may also like

  • 3 Biggest Benefits Policy Developments from 2024’s 1st Half

    3 Biggest Benefits Policy Developments from 2024’s 1st Half

    COVERAGE

    3 Biggest Benefits Policy Developments from 2024’s 1st Half

    June 28, 2024

    Read time: 2 min

    About Us

    Sarah G. Raaii

    Partner

    Chicago

    You may also like

  • Insurer Climate Risk Report Drawing Regulatory Attention

    Insurer Climate Risk Report Drawing Regulatory Attention

    COVERAGE

    Insurer Climate Risk Report Drawing Regulatory Attention

    June 27, 2024

    Read time: 2 min

    About Us

    Thomas M. Dawson

    Partner

    New York – One Vanderbilt Avenue

    You may also like

  • Post-‘Chevron’: Lower Court Fights Are Expected Over Ability to Challenge Pre-‘Loper’ Agency Rules

    Post-‘Chevron’: Lower Court Fights Are Expected Over Ability to Challenge Pre-‘Loper’ Agency Rules

    COVERAGE

    Post-‘Chevron’: Lower Court Fights Are Expected Over Ability to Challenge Pre-‘Loper’ Agency Rules

    June 28, 2024

    Read time: 2 min

    About Us

    Paul W. Hughes

    Partner

    Washington, DC

    You may also like